PubMed:10810403 / 1302-1474 JSONTXT

Annnotations TAB JSON ListView MergeView

c_corpus

Id Subject Object Predicate Lexical cue
T275 0-11 C032690 denotes 17 beta-HSD
T273 0-11 GO:0004303 denotes 17 beta-HSD
T274 0-11 GO:0047035 denotes 17 beta-HSD
T278 8-11 PR:P35492 denotes HSD
T280 8-11 PR:000008437 denotes HSD
T279 8-11 143095 denotes HSD
T281 127-133 UBERON:0000310 denotes breast
T282 149-155 UBERON:0000310 denotes breast
T283 149-165 D001943 denotes breast carcinoma
T284 149-165 D001943 denotes breast carcinoma

PubmedHPO

Id Subject Object Predicate Lexical cue
T7 149-165 HP_0003002 denotes breast carcinoma

UseCases_ArguminSci_Discourse

Id Subject Object Predicate Lexical cue
T7 0-172 DRI_Background denotes 17 beta-HSD type 2 immunoreactivity was sporadically detected in non-proliferative or Ki67 negative ductal epithelia of normal breast, but rarely in breast carcinoma cells.

PubMed_ArguminSci

Id Subject Object Predicate Lexical cue
T6 0-172 DRI_Background denotes 17 beta-HSD type 2 immunoreactivity was sporadically detected in non-proliferative or Ki67 negative ductal epithelia of normal breast, but rarely in breast carcinoma cells.